Antibody Fragment-Conjugated Nanosystems for Targeted Therapy of Brain Infections (TARBRAINFECT)

Antibody Fragment-Conjugated Nanosystems for Targeted Therapy of Brain Infections (TARBRAINFECT)

Antibody Fragment-Conjugated Nanosystems for Targeted Therapy of Brain Infections (TARBRAINFECT)

16/EuroNanoMed/2019, Agreement signed on: 16.07.2019 Between 2019 and 2023, NanoSanguis implemented the project titled “Nanosystems Conjugated with Antibody Fra…

Nanoporous Membranes for Intrathecal (Pseudo)Delivery of Drugs (INTREPIDUS)

Nanoporous Membranes for Intrathecal (Pseudo)Delivery of Drugs (INTREPIDUS)

ENM3/IV/1/INTREPIDUS/2021, Agreement signed on: 17.12.2021 Between 2021 and 2024, NanoSanguis implemented the project titled “Nanoporous Membranes for Intrathec…

Development of a Significantly Improved Device for Normothermic Organ Perfusion in the Field of Transplantation.

Development of a Significantly Improved Device for Normothermic Organ Perfusion in the Field of Transplantation.

POIR.02.03.02-14-0022/19-02 Between 2019 and 2023, NanoSanguis implemented a project co-financed by the European Funds entitled “Development of a&nbsp…

Development of Innovative Nanopharmaceuticals Against Bacterial Infections in the Central Nervous System (ANTINEUROPATHO).

Development of Innovative Nanopharmaceuticals Against Bacterial Infections in the Central Nervous System (ANTINEUROPATHO).

ENM3/V/33/Antineuropatho/2023, Agreement signed on: 30.08.2023 NanoSanguis S.A. is implementing the project titled “Developing Novel Nanopharmaceutics Against B…

OrganFarm – System for Long-Term Ex Vivo Organ Storage.

OrganFarm – System for Long-Term Ex Vivo Organ Storage.

POIR.01.01.01-00-0332/16 Between 2016 and 2024, NanoSanguis implemented a project co-financed by the European Funds entitled “OrganFarm – a syste…

Red Blood Cell Substitute

Red Blood Cell Substitute

RPMA.01.02.00-14-5721/16 Between 2016 and 2022, NanoSanguis implemented a project co-financed by the European Funds entitled “Red Blood Cell Substitut…

pp-thumbnail